Pancreatic Insufficiency Completed Phase 1 / 2 Trials for Burlulipase (DB12871)

Also known as: Pancreatic failure / Pancreatic insufficiency (disorder) / Insufficiency pancreatic / Exocrine pancreatic insufficiency / Pancreatic exocrine insufficiency / Exocrine pancreatic insufficiency (disorder)

IndicationStatusPhase
DBCOND0031191 (Pancreatic Insufficiency)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01710644Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic FibrosisTreatment